Market Opportunity

ALMOST 1 in 5 of the European population suffers moderate or severe pain persisting for more than 6 months; this corresponds to 100 million people in the EU alone.

The global chronic pain prescription drug market is estimated to $ 36 billion, with 50% of predicted sales in the US.

  • Treatment of chronic pain is still a clearly unmet medical need.

Find us

PharmNovo AB
Medicon Village AB
Scheelevägen 6
SE-223 81 Lund, Sweden